Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

Benzer Materyaller

• Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.
  Yazar:: Barbara A Friedland, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)
• Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
  Yazar:: Kenneth Ngure, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-01-01)
• Analyzing Pricing Strategies of MTN-Irancell
  Yazar:: mohsen nazari, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-02-01)
• Exploring pregnant women’s experiences with dapivirine vaginal ring insertion during the MTN-042/DELIVER study in Uganda: a description of secondary data
  Yazar:: Joselyne Nansimbe, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-04-01)
• Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN‐003 (VOICE) study
  Yazar:: Ariane van derStraten, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)